Stock News

A-R-T- Advisors Decreased Biocryst Pharmaceuticals (BCRX) Stake; Monro (MNRO) Shorts Raised By 7.69%

BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) Logo

Monro Inc (NASDAQ:MNRO) had an increase of 7.69% in short interest. MNRO’s SI was 3.95M shares in April as released by FINRA. Its up 7.69% from 3.67M shares previously. With 264,600 avg volume, 15 days are for Monro Inc (NASDAQ:MNRO)’s short sellers to cover MNRO’s short positions. The SI to Monro Inc’s float is 13.32%. The stock decreased 0.46% or $0.25 during the last trading session, reaching $53.55. About 318,146 shares traded or 0.03% up from the average. Monro, Inc. (NASDAQ:MNRO) has declined 0.29% since April 21, 2017 and is downtrending. It has underperformed by 11.84% the S&P500.

A-R-T- Advisors Llc decreased Biocryst Pharmaceuticals (BCRX) stake by 93.57% reported in 2017Q4 SEC filing. A-R-T- Advisors Llc sold 239,214 shares as Biocryst Pharmaceuticals (BCRX)’s stock declined 0.98%. The A-R-T- Advisors Llc holds 16,452 shares with $80,000 value, down from 255,666 last quarter. Biocryst Pharmaceuticals now has $484.16M valuation. The stock increased 1.45% or $0.07 during the last trading session, reaching $4.91. About 503,158 shares traded. BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) has declined 43.31% since April 21, 2017 and is downtrending. It has underperformed by 54.86% the S&P500.

Investors sentiment increased to 1.43 in Q4 2017. Its up 0.01, from 1.42 in 2017Q3. It improved, as 17 investors sold Monro, Inc. shares while 51 reduced holdings. 33 funds opened positions while 64 raised stakes. 35.34 million shares or 0.96% less from 35.68 million shares in 2017Q3 were reported. Us National Bank De accumulated 1,634 shares or 0% of the stock. State Of Alaska Department Of Revenue reported 6,531 shares stake. Timessquare Management Ltd Liability Corporation reported 973,709 shares or 0.36% of all its holdings. 89,646 were accumulated by California Pub Employees Retirement System. Texas Permanent School Fund reported 0.02% stake. Summit Creek Advisors Limited Com invested in 230,561 shares. State Street reported 954,426 shares stake. Public Employees Retirement Association Of Colorado owns 6,251 shares for 0% of their portfolio. 329,995 were reported by Granite Prtnrs Limited Liability. Deutsche Bancshares Ag reported 0% of its portfolio in Monro, Inc. (NASDAQ:MNRO). Goldman Sachs Gp has 106,080 shares. Peak6 Limited Partnership invested in 111,379 shares or 0.03% of the stock. Credit Suisse Ag accumulated 33,648 shares or 0% of the stock. 55,081 were reported by Arizona State Retirement System. Columbia Wanger Asset Mngmt Limited Liability Corp reported 0.42% of its portfolio in Monro, Inc. (NASDAQ:MNRO).

Since February 5, 2018, it had 0 insider buys, and 2 insider sales for $708,100 activity. Another trade for 3,000 shares valued at $153,000 was sold by Mulholland Maureen. MCCLUSKI STEPHEN C had sold 10,000 shares worth $555,100.

Monro, Inc. provides automotive undercar repair, and tire sales and services in the United States. The company has market cap of $1.76 billion. The firm offers range of services on passenger cars, light trucks, and vans for brakes; mufflers and exhaust systems; and steering, drive train, suspension, and wheel alignment. It has a 31.78 P/E ratio. It also provides other services and products, including tires and routine maintenance services, including state inspections.

Among 14 analysts covering Monro Muffler Brake (NASDAQ:MNRO), 5 have Buy rating, 0 Sell and 9 Hold. Therefore 36% are positive. Monro Muffler Brake had 30 analyst reports since August 5, 2015 according to SRatingsIntel. The company was upgraded on Tuesday, January 31 by Gabelli. CL King initiated the shares of MNRO in report on Monday, September 28 with “Neutral” rating. The rating was downgraded by Susquehanna to “Neutral” on Tuesday, June 20. The firm has “Buy” rating given on Tuesday, June 20 by Oppenheimer. The stock of Monro, Inc. (NASDAQ:MNRO) earned “Equal-Weight” rating by Stephens on Thursday, June 29. The rating was maintained by Oppenheimer with “Buy” on Wednesday, June 28. KeyBanc Capital Markets downgraded the shares of MNRO in report on Wednesday, August 19 to “Sector Weight” rating. Evercore upgraded it to “Hold” rating and $71 target in Wednesday, August 5 report. The rating was initiated by Jefferies with “Buy” on Tuesday, September 15. The stock of Monro, Inc. (NASDAQ:MNRO) has “Hold” rating given on Tuesday, October 24 by KeyBanc Capital Markets.

A-R-T- Advisors Llc increased Pinnacle Foods Inc Del (NYSE:PF) stake by 74,678 shares to 120,878 valued at $7.19 million in 2017Q4. It also upped Mid Amer Apt Cmntys Inc (NYSE:MAA) stake by 6,900 shares and now owns 27,574 shares. Agnico Eagle Mines Ltd (NYSE:AEM) was raised too.

Analysts await BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) to report earnings on May, 3. They expect $-0.16 EPS, up 15.79% or $0.03 from last year’s $-0.19 per share. After $-0.20 actual EPS reported by BioCryst Pharmaceuticals, Inc. for the previous quarter, Wall Street now forecasts -20.00% EPS growth.

Monro, Inc. (NASDAQ:MNRO) Institutional Positions Chart

Leave a Reply

Your email address will not be published. Required fields are marked *